35955492|t|Transcriptomic Analysis Reveals That Granulocyte Colony-Stimulating Factor Trigger a Novel Signaling Pathway (TAF9-P53-TRIAP1-CASP3) to Protect Retinal Ganglion Cells after Ischemic Optic Neuropathy.
35955492|a|Optic nerve head (ONH) infarct can result in progressive retinal ganglion cell (RGC) death. The granulocyte colony-stimulating factor (GCSF) protects the RGC after ON infarct. However, protective mechanisms of the GCSF after ONH infarct are complex and remain unclear. To investigate the complex mechanisms involved, the transcriptome profiles of the GCSF-treated retinas were examined using microarray technology. The retinal mRNA samples on days 3 and 7 post rat anterior ischemic optic neuropathy (rAION) were analyzed by microarray and bioinformatics analyses. GCSF treatment influenced 3101 genes and 3332 genes on days 3 and 7 post rAION, respectively. ONH infarct led to changes in 702 and 179 genes on days 3 and 7 post rAION, respectively. After cluster analysis, the levels of TATA box-binding protein (TBP)-associated factor were significantly reduced after ONH infarct, but these significantly increased after GCSF treatment. The network analysis revealed that TBP associated factor 9 (TAF9) can bind to P53 to induce TP53-regulated inhibitor of apoptosis 1 (TRIAP1) expression. To evaluate the function of TAF9 in RGC apoptosis, GCSF plus TAF9 siRNA-treated rats were evaluated using retrograde labeling with FluoroGold assay, TUNEL assay, and Western blotting in an rAION model. The RGC densities in the GCSF plus TAF9 siRNA-treated rAION group were 1.95-fold (central retina) and 1.75-fold (midperipheral retina) lower than that in the GCSF-treated rAION group (p < 0.05). The number of apoptotic RGC in the GCSF plus TAF9 siRNA-treated group was threefold higher than that in the GCSF-treated group (p < 0.05). Treatment with TAF9 siRNA significantly reduced GCSF-induced TP53 and TRIAP1 expression by 2.4-fold and 4.7-fold, respectively, in the rAION model. Overexpression of TAF9 significantly reduced apoptotic RGC and CASP3 levels, and induced TP53 and TRIAP1 expression in the rAION model. Therefore, we have demonstrated that GCSF modulated a new pathway, TAF9-P53-TRIAP1-CASP3, to control RGC death and survival after ON infarct.
35955492	37	74	Granulocyte Colony-Stimulating Factor	Gene	25610
35955492	110	114	TAF9	Gene	373541
35955492	115	118	P53	Gene	24842
35955492	119	125	TRIAP1	Gene	691278
35955492	126	131	CASP3	Gene	25402
35955492	173	198	Ischemic Optic Neuropathy	Disease	MESH:D018917
35955492	200	218	Optic nerve head (	Disease	MESH:D006259
35955492	218	230	ONH) infarct	Disease	MESH:D007238
35955492	257	280	retinal ganglion cell (	Disease	MESH:D012173
35955492	283	290	) death	Disease	MESH:D003643
35955492	296	333	granulocyte colony-stimulating factor	Gene	25610
35955492	335	339	GCSF	Gene	25610
35955492	364	374	ON infarct	Disease	MESH:D007238
35955492	414	418	GCSF	Gene	25610
35955492	425	436	ONH infarct	Disease	MESH:D007238
35955492	551	555	GCSF	Gene	25610
35955492	661	664	rat	Species	10116
35955492	665	699	anterior ischemic optic neuropathy	Disease	MESH:D018917
35955492	701	706	rAION	Disease	MESH:D018917
35955492	765	769	GCSF	Gene	25610
35955492	838	843	rAION	Disease	MESH:D018917
35955492	859	870	ONH infarct	Disease	MESH:D007238
35955492	928	933	rAION	Disease	MESH:D018917
35955492	987	1011	TATA box-binding protein	Gene	117526
35955492	1013	1016	TBP	Gene	117526
35955492	1069	1080	ONH infarct	Disease	MESH:D007238
35955492	1122	1126	GCSF	Gene	25610
35955492	1173	1196	TBP associated factor 9	Gene	373541
35955492	1198	1202	TAF9	Gene	373541
35955492	1216	1219	P53	Gene	24842
35955492	1230	1234	TP53	Gene	24842
35955492	1271	1277	TRIAP1	Gene	691278
35955492	1319	1323	TAF9	Gene	373541
35955492	1342	1346	GCSF	Gene	25610
35955492	1352	1356	TAF9	Gene	373541
35955492	1371	1375	rats	Species	10116
35955492	1480	1485	rAION	Disease	MESH:D018917
35955492	1518	1522	GCSF	Gene	25610
35955492	1528	1532	TAF9	Gene	373541
35955492	1547	1552	rAION	Disease	MESH:D018917
35955492	1651	1655	GCSF	Gene	25610
35955492	1664	1669	rAION	Disease	MESH:D018917
35955492	1723	1727	GCSF	Gene	25610
35955492	1733	1737	TAF9	Gene	373541
35955492	1796	1800	GCSF	Gene	25610
35955492	1842	1846	TAF9	Gene	373541
35955492	1875	1879	GCSF	Gene	25610
35955492	1888	1892	TP53	Gene	24842
35955492	1897	1903	TRIAP1	Gene	691278
35955492	1962	1967	rAION	Disease	MESH:D018917
35955492	1993	1997	TAF9	Gene	373541
35955492	2038	2043	CASP3	Gene	25402
35955492	2064	2068	TP53	Gene	24842
35955492	2073	2079	TRIAP1	Gene	691278
35955492	2098	2103	rAION	Disease	MESH:D018917
35955492	2148	2152	GCSF	Gene	25610
35955492	2178	2182	TAF9	Gene	373541
35955492	2183	2186	P53	Gene	24842
35955492	2187	2193	TRIAP1	Gene	691278
35955492	2194	2199	CASP3	Gene	25402
35955492	2241	2251	ON infarct	Disease	MESH:D007238
35955492	Association	25402	691278
35955492	Negative_Correlation	MESH:D007238	25610
35955492	Association	MESH:D018917	24842
35955492	Association	25610	373541
35955492	Association	MESH:D018917	25402
35955492	Association	MESH:D018917	691278
35955492	Positive_Correlation	117526	25610
35955492	Association	24842	25610
35955492	Association	24842	691278
35955492	Positive_Correlation	373541	691278
35955492	Negative_Correlation	MESH:D007238	117526
35955492	Association	25402	25610
35955492	Association	MESH:D018917	373541
35955492	Association	25610	691278
35955492	Association	MESH:D018917	25610
35955492	Positive_Correlation	24842	373541

